186 related articles for article (PubMed ID: 32487151)
1. Craniospinal irradiation(CSI) in patients with leptomeningeal metastases: risk-benefit-profile and development of a prognostic score for decision making in the palliative setting.
Devecka M; Duma MN; Wilkens JJ; Kampfer S; Borm KJ; Münch S; Straube C; Combs SE
BMC Cancer; 2020 Jun; 20(1):501. PubMed ID: 32487151
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of craniospinal irradiation for leptomeningeal disease: past, present, and future.
Maillie L; Salgado LR; Lazarev S
Clin Transl Oncol; 2021 Oct; 23(10):2109-2119. PubMed ID: 33881707
[TBL] [Abstract][Full Text] [Related]
3. A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases.
Yin K; Li YS; Zheng MM; Jiang BY; Li WF; Yang JJ; Tu HY; Zhou Q; Zhong WZ; Yang XN; Chen HJ; Yan HH; Li LL; Wu YL; Zhang XC
Lung Cancer; 2019 May; 131():134-138. PubMed ID: 31027690
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
[TBL] [Abstract][Full Text] [Related]
5. Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis.
El Shafie RA; Böhm K; Weber D; Lang K; Schlaich F; Adeberg S; Paul A; Haefner MF; Katayama S; Sterzing F; Hörner-Rieber J; Löw S; Herfarth K; Debus J; Rieken S; Bernhardt D
Cancer Manag Res; 2019; 11():789-801. PubMed ID: 30697071
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy of the neuroaxis for palliative treatment of leptomeningeal carcinomatosis.
Hermann B; Hültenschmidt B; Sautter-Bihl ML
Strahlenther Onkol; 2001 Apr; 177(4):195-9. PubMed ID: 11370554
[TBL] [Abstract][Full Text] [Related]
7. The clinical characteristic and prognostic factors of leptomeningeal metastasis in patients with non-small-cell lung cancer-a retrospective study from one single cancer institute.
Yan W; Jing W; An N; Tian Y; Guo D; Kong L; Zhu H; Yu J
Cancer Med; 2019 Jun; 8(6):2769-2776. PubMed ID: 30993909
[TBL] [Abstract][Full Text] [Related]
8. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
9. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
Kuiper JL; Hendriks LE; van der Wekken AJ; de Langen AJ; Bahce I; Thunnissen E; Heideman DA; Berk Y; Buijs EJ; Speel EJ; Krouwels FH; Smit HJ; Groen HJ; Dingemans AM; Smit EF
Lung Cancer; 2015 Sep; 89(3):255-61. PubMed ID: 26117231
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy.
Morris PG; Reiner AS; Szenberg OR; Clarke JL; Panageas KS; Perez HR; Kris MG; Chan TA; DeAngelis LM; Omuro AM
J Thorac Oncol; 2012 Feb; 7(2):382-5. PubMed ID: 22089116
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial of proton craniospinal irradiation for leptomeningeal metastases.
Yang TJ; Wijetunga NA; Yamada J; Wolden S; Mehallow M; Goldman DA; Zhang Z; Young RJ; Kris MG; Yu HA; Seidman AD; Gavrilovic IT; Lin A; Santomasso B; Grommes C; Piotrowski AF; Schaff L; Stone JB; DeAngelis LM; Boire A; Pentsova E
Neuro Oncol; 2021 Jan; 23(1):134-143. PubMed ID: 32592583
[TBL] [Abstract][Full Text] [Related]
13. Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma.
Croog VJ; Kramer K; Cheung NK; Kushner BH; Modak S; Souweidane MM; Wolden SL
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):849-54. PubMed ID: 20207502
[TBL] [Abstract][Full Text] [Related]
14. Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors.
Ozdemir Y; Yildirim BA; Topkan E
J Neurooncol; 2016 Sep; 129(2):329-35. PubMed ID: 27306442
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors.
Waki F; Ando M; Takashima A; Yonemori K; Nokihara H; Miyake M; Tateishi U; Tsuta K; Shimada Y; Fujiwara Y; Tamura T
J Neurooncol; 2009 Jun; 93(2):205-12. PubMed ID: 19043775
[TBL] [Abstract][Full Text] [Related]
16. Pemetrexed in the Treatment of Leptomeningeal Metastasis in Patients With EGFR-mutant Lung Cancer.
Choi M; Keam B; Ock CY; Kim M; Kim TM; Kim DW; Heo DS
Clin Lung Cancer; 2019 Jul; 20(4):e442-e451. PubMed ID: 31010639
[TBL] [Abstract][Full Text] [Related]
17. Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation.
Barney CL; Brown AP; Grosshans DR; McAleer MF; de Groot JF; Puduvalli V; Tucker SL; Crawford CN; Gilbert MR; Brown PD; Mahajan A
Neuro Oncol; 2014 Jan; 16(2):303-9. PubMed ID: 24311638
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group.
Firat S; Byhardt RW; Gore E
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):357-64. PubMed ID: 12243808
[TBL] [Abstract][Full Text] [Related]
19. Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors.
Hendriks LEL; Bootsma G; Mourlanette J; Henon C; Mezquita L; Ferrara R; Audigier-Valette C; Mazieres J; Lefebvre C; Duchemann B; Cousin S; le Pechoux C; Botticella A; De Ruysscher D; Dingemans AC; Besse B
Eur J Cancer; 2019 Jul; 116():182-189. PubMed ID: 31203193
[TBL] [Abstract][Full Text] [Related]
20. Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patients.
Du C; Hong R; Shi Y; Yu X; Wang J
J Neurooncol; 2013 Nov; 115(2):285-91. PubMed ID: 24000114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]